Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More
PM360
SEPTEMBER 21, 2023
A generic here will improve access in OAB to a product with less side effects, which is especially important in the elderly population, Casberg noted. This product would be a more potent prescription version than the OTCs, Casberg notes. Starting in 2026, the provision will affect 10 Part D drugs.
105 
Let's personalize your content